Global Flu RNA Vaccines Market Growth 2025-2031

The global Flu RNA Vaccines market size is predicted to grow from US$ 1143 million in 2025 to US$ 2020 million in 2031; it is expected to grow at a CAGR of 10.0% from 2025 to 2031.

Flu RNA Vaccines, commonly known as flu vaccines, are designed to protect against the influenza virus. The influenza virus can cause respiratory illnesses ranging from mild to severe, and vaccination is an effective way to prevent or reduce the severity of flu infections.

Flu RNA Vaccines are an important public health measure to prevent the spread of the influenza virus and reduce the risk of severe illness, hospitalization, and death associated with the flu.

United States market for Flu RNA Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Flu RNA Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Flu RNA Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Flu RNA Vaccines players cover Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Flu RNA Vaccines Industry Forecast” looks at past sales and reviews total world Flu RNA Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Flu RNA Vaccines sales for 2025 through 2031. With Flu RNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu RNA Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Flu RNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu RNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Flu RNA Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu RNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu RNA Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Flu RNA Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Non-Replicating mRNA

In Vivo Self-Replicating mRNA

In Vitro Dendritic Cell Non-Replicating mRNA Vaccine

Others

Segmentation by Application:

Hospitals

Vaccination Center

Specialized Clinics

Hospital Pharmacy

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Sanofi Pasteur Inc.

AstraZeneca

CSL Ltd.

Abbott

GlaxoSmithKline Plc.

Serum Institute of India Pvt. Ltd.

Pfizer

BioNTech

F.Hoffman La Roche Ltd

Novartis

Sinnovac Biotech Ltd

Moderna Therapeutics

CureVac

Key Questions Addressed in this Report

What is the 10-year outlook for the global Flu RNA Vaccines market?

What factors are driving Flu RNA Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Flu RNA Vaccines market opportunities vary by end market size?

How does Flu RNA Vaccines break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.